Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases

H Tomková1, W Fujimoto, J Arata

  • 1Department of Dermatology, Okayama University Medical School, Japan.

Insights

The proapoptotic protein Bak is expressed in normal skin and various skin diseases. Loss of Bak expression, along with Bcl-2 overexpression, may contribute to basal cell carcinoma development.

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Bak (bcl-2 homologous antagonist/killer) is a proapoptotic protein crucial for regulating programmed cell death.
  • The bcl-2 gene family includes oncogenes involved in cell death regulation.
  • Understanding Bak expression in skin diseases is important for pathogenesis research.

Purpose of the Study:

  • To investigate the expression patterns of Bak in normal skin and various inflammatory and neoplastic skin conditions.
  • To compare Bak expression in different skin layers and appendages.
  • To explore the potential role of Bak in the pathogenesis of basal cell carcinoma.

Main Methods:

  • Immunohistochemical analysis of skin tissue samples.
  • Immunoblot analysis of cultured human epidermal keratinocytes.

Main Results:

  • Positive Bak staining was observed in epidermal keratinocytes of normal skin and in psoriasis vulgaris, lichen planus, actinic keratosis, keratoacanthoma, and squamous cell carcinoma.
  • Bak was expressed in the follicular infundibulum but showed weak or negative expression in the outer root sheath.
  • Seventeen of 20 basal cell carcinomas exhibited negative Bak immunostaining, with three showing weak positivity.

Conclusions:

  • Bak is expressed in various skin compartments and diseases.
  • The loss of Bak expression in basal cell carcinoma, potentially alongside Bcl-2 overexpression, may play a role in its pathogenesis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...